Articles

Read the latest articles relevant to your clinical practice, including exclusive insights from Healthed surveys and polls.

By reading selected clinical articles, you earn CPD in the Educational Activities (EA) category whenever you click the “Claim CPD” button and follow the prompts. 

Filter results

There appears to be a myriad of potential treatments for our current health threat – COVID19. But just how real are these options? And which if any of these are likely to make it into our treatment regimens? A review just published online in JAMA gives us a neat summary of where we are up to in terms of treatment.

As discussed by Prof Bernie Hudson, Director of Microbiology and Infectious Diseases at Royal North Shore Hospital, Sydney in his interview with Dr Harry Nespolon on Going Viral According to a recent analysis of COVID-19 cases among patients aged over 18 years.

Scott Morrison has made clear his view that any attempt to eliminate COVID-19 entirely in Australia would carry too high an economic cost, while Chief Medical Officer Brendan Murphy says such an aim would require “very aggressive” long-term border control.

Having some evidence-based guidelines on when a COVID-positive patient needs hospitalisation is likely to be welcomed by the GP currently managing these self-isolating patients.

Sudden loss of smell could be a sign of COVID-19, say ENT specialists from around the world, even in the absence of other symptoms. The experts from the UK, the US and Australia are calling for anosmia to be added to the list of possible symptoms to be asked about when screening for potentially having the virus.

The key points from Dr Harry Nespolon’s interview with Avant’s Ms Georgie Haysom, Head of Research Education and Advocacy and Dr Penny Browne, Chief Medical Officer.

While many scientists are working on developing a coronavirus vaccine, others are busy testing antiviral drugs. Vaccines are generally only effective when administered prior to infection, but antiviral agents are important because they can treat people who already have COVID-19.

So how much are you at risk of COVID-19 from the door handle in your surgery? Or your desktop? Or the arm of the patient’s chair? Basically the question is how long can this nasty little coronavirus remain viable on the different surfaces in your practice? Well according to Clinical Microbiologist and Infectious Diseases Physician, Dr Bernie Hudson,  COVID-19 can persist and be potentially dangerous up to a week on certain surfaces. Scary isn’t it?

There’s been some confusion recently on whether we should or shouldn’t take ibuprofen to treat symptoms of COVID-19 – especially after the World Health Organization (WHO) changed its stance. After initially recommending people avoid taking ibuprofen to treat symptoms of the new coronavirus disease, as of March 19 the WHO now does not recommend avoiding ibuprofen to treat COVID-19 symptoms.

With all the debate about whether or not schools should be closed the question has to be asked – how risky is this coronavirus pandemic to children?

When it comes to protection in your practice, surgical face masks to limit droplet transmission are the standard recommendation, assuming you can get ahold of them – but what about when seeing patients who have or may have COVID-19?

While the majority of patients infected with COVID-19 will not require treatment, there is new hope for those that do go on to become seriously ill. A few treatments developed for other illnesses are showing promise, says Clinical Microbiologist and Infectious Diseases Physician Dr Bernard Hudson.

There appears to be a myriad of potential treatments for our current health threat – COVID19. But just how real are these options? And which if any of these are likely to make it into our treatment regimens? A review just published online in JAMA gives us a neat summary of where we are up to in terms of treatment.

Clinical Articles iconClinical Articles

As discussed by Prof Bernie Hudson, Director of Microbiology and Infectious Diseases at Royal North Shore Hospital, Sydney in his interview with Dr Harry Nespolon on Going Viral According to a recent analysis of COVID-19 cases among patients aged over 18 years.

Clinical Articles iconClinical Articles

Scott Morrison has made clear his view that any attempt to eliminate COVID-19 entirely in Australia would carry too high an economic cost, while Chief Medical Officer Brendan Murphy says such an aim would require “very aggressive” long-term border control.

Clinical Articles iconClinical Articles

Having some evidence-based guidelines on when a COVID-positive patient needs hospitalisation is likely to be welcomed by the GP currently managing these self-isolating patients.

Clinical Articles iconClinical Articles

Sudden loss of smell could be a sign of COVID-19, say ENT specialists from around the world, even in the absence of other symptoms. The experts from the UK, the US and Australia are calling for anosmia to be added to the list of possible symptoms to be asked about when screening for potentially having the virus.

Clinical Articles iconClinical Articles

The key points from Dr Harry Nespolon’s interview with Avant’s Ms Georgie Haysom, Head of Research Education and Advocacy and Dr Penny Browne, Chief Medical Officer.

Clinical Articles iconClinical Articles

While many scientists are working on developing a coronavirus vaccine, others are busy testing antiviral drugs. Vaccines are generally only effective when administered prior to infection, but antiviral agents are important because they can treat people who already have COVID-19.

Clinical Articles iconClinical Articles

So how much are you at risk of COVID-19 from the door handle in your surgery? Or your desktop? Or the arm of the patient’s chair? Basically the question is how long can this nasty little coronavirus remain viable on the different surfaces in your practice? Well according to Clinical Microbiologist and Infectious Diseases Physician, Dr Bernie Hudson,  COVID-19 can persist and be potentially dangerous up to a week on certain surfaces. Scary isn’t it?

Clinical Articles iconClinical Articles

There’s been some confusion recently on whether we should or shouldn’t take ibuprofen to treat symptoms of COVID-19 – especially after the World Health Organization (WHO) changed its stance. After initially recommending people avoid taking ibuprofen to treat symptoms of the new coronavirus disease, as of March 19 the WHO now does not recommend avoiding ibuprofen to treat COVID-19 symptoms.

Clinical Articles iconClinical Articles

With all the debate about whether or not schools should be closed the question has to be asked – how risky is this coronavirus pandemic to children?

Clinical Articles iconClinical Articles

When it comes to protection in your practice, surgical face masks to limit droplet transmission are the standard recommendation, assuming you can get ahold of them – but what about when seeing patients who have or may have COVID-19?

Clinical Articles iconClinical Articles

While the majority of patients infected with COVID-19 will not require treatment, there is new hope for those that do go on to become seriously ill. A few treatments developed for other illnesses are showing promise, says Clinical Microbiologist and Infectious Diseases Physician Dr Bernard Hudson.

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

Rosacea – Smarter diagnosis & state-of-the-art care

Tuesday 14th April, 7pm - 9pm AEST

Speaker

Dr Belinda Welsh

Dermatologist; Senior Vice President, Australasian Society of Cosmetic Dermatologists

Join Dr Belinda Welsh, who will also present a practical framework for the effective management of rosacea, a condition that can be controlled by not cured.